Metabolic Changes in Blood Samples from Patients with Acute Myeloid Leukemia

Inclusion Criteria

• Patients scheduled to initiate chemotherapy for either an initial diagnosis of AML or relapsed AML will be approached to participate
• Only patients starting the initial induction phase of therapy are eligible
• Prior exposure to hydroxyurea is acceptable but must be noted at the time of sample collection
• Patients must have the ability to understand and the willingness to sign an Institutional Review Board (IRB)-approved informed consent document in order to participate in this study

Exclusion Criteria

• Patients who have already received 1 or more doses of chemotherapy for their present diagnosis will be excluded